| 2005N-0345 | Drug Approvals: Circumstances under which an active ingredient may be simultaneously marketed in both a prescription drug product and an over-the-counter drug product | |||||||||||||||||||||||
| FDA Comment Number : | EC17 | |||||||||||||||||||||||
| Submitter : | Mr. Rick LaChance | Date & Time: | 09/01/2005 04:09:18 | |||||||||||||||||||||
| Organization : | Mr. Rick LaChance | |||||||||||||||||||||||
| Category : | Individual Consumer | |||||||||||||||||||||||
| Issue Areas/Comments | ||||||||||||||||||||||||
| GENERAL | ||||||||||||||||||||||||
| GENERAL | ||||||||||||||||||||||||
| Sales to minors should be regulated the same way alcohol is sold - with an ID only. | ||||||||||||||||||||||||